4-Bromo-5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98.0%, 1g

trans-4-[2-(4-Pentylcyclohexyl)ethyl]cyclohexanone, 95.0%, 1g

2-(5-FLUORO-1H-INDOL-3-YL)ETHANOL, 95.0%, 1g

3-(3,5-Dichlorophenyl)-1,2-oxazol-5-amine, 95+%, 1g

(5E)-5-(4-tert-butylbenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g

2-Amino-2-[2-(trifluoromethyl)phenyl]ethan-1-ol, 97%, 500mg

2-(2-(4-Chlorophenyl)thiazol-4-yl)ethan-1-amine hydrochloride, 95%, 1g

Bromoacetyl Chloride>85.0%(GC)25g

1,1':4',1''-Terphenyl-2-boronic acid, 97.0%, 10g

(4-Methoxy-3-(trifluoromethyl)phenyl)boronic acid, 95.0%, 5g

Oxalic acid diimidazolide, 95.0%, 1g

{3-[(1-Benzyl-1H-indazol-3-yl)oxy]propyl}dimethylamine hydrochloride, 97.0%, 100g

1-(8-methylimidazo[1,2-a]pyridin-3-yl)methanamine, 95.0%, 250mg